Detalles de la búsqueda
1.
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Cardiovasc Drugs Ther
; 37(5): 965-974, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35648242
2.
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomized controlled trial.
Rheumatology (Oxford)
; 61(6): 2346-2359, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605897
3.
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
Eur Heart J
; 40(22): 1778-1786, 2019 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30844048
4.
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study).
Diabetes Ther
; 15(6): 1403-1416, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653904
5.
Impacts of Febuxostat on Cerebral and Cardiovascular Events in Elderly Patients with Hyperuricemia: Post Hoc Analysis of a Randomized Controlled Trial.
Clin Pharmacol Ther
; 115(6): 1358-1364, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38389505
6.
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).
Diabetes Ther
; 14(10): 1639-1658, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468684
7.
Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study).
Diabetes Ther
; 14(9): 1517-1535, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410308
8.
Febuxostat and renal outcomes: post-hoc analysis of a randomized trial.
Hypertens Res
; 46(6): 1417-1422, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750608
9.
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
Int J Cardiol
; 349: 127-133, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864084
10.
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
J Cardiol
; 69(1): 169-175, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27005768
Resultados
1 -
10
de 10
1
Próxima >
>>